Ye Zong

Dec 30, 2024 | mdpi.com | Ye Zong

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessCase Report by Qi Li and Ye Zong * National Clinical Research Center for Digestive Diseases, State Key Laboratory for Digestive Health, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China *Author to whom correspondence should be addressed.

Oct 21, 2024 | tandfonline.com | Ye Zong |Xing LI |Weixing chen |Honghui Chen

AbstractObjective Tegoprazan represents a newly developed potassium-competitive acid blocker utilized for the treatment of acid-related disorders. The present study aimed to explore the therapeutic effectiveness of tegoprazan in Chinese individuals with duodenal ulcers (DU).